E16.2 Hypoglycaemia, unspecified - analogs
| Description «E16.2 Hypoglycaemia, unspecified» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 18% Compare E10-E14 Diabetes mellitus
- 17% Compare A70 Chlamydia psittaci infection
- 16% Compare A46 Erysipelas
- 16% Compare M30.0 Polyarteritis nodosa
- 15% Compare J18.1 Lobar pneumonia, unspecified
- 14% Compare F01 Vascular dementia
- 14% Compare J03 Acute tonsillitis
- 14% Compare M86.0 Acute haematogenous osteomyelitis
- 13% Compare O24 Diabetes mellitus in pregnancy
- 13% Compare T42 Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs
- 13% Compare B46 Zygomycosis
- 12% Compare E10 Type 1 diabetes mellitus
- 12% Compare I26-I28 Pulmonary heart and pulmonary circulation disorders
- 11% Compare J93.0 Spontaneous tension pneumothorax
- 11% Compare A98.4 Ebola virus disease
- 10% Compare G47 Sleep disorders
- 10% Compare F40-F48 Neurotic, stress-related and somatoform disorders
- 10% Compare G03.9 Meningitis, unspecified
- 10% Compare K51.0 Ulcerative (chronic) pancolitis
- 10% Compare F10.0 Mental and behavioural disorders due to use of alcohol, acute intoxication
- 10% Compare K86 Other diseases of pancreas
- 10% Compare M05.2 Rheumatoid vasculitis
- 10% Compare M12.1 Kaschin-Beck disease
- 10% Compare K86.0 Alcohol-induced chronic pancreatitis
Learn more about the selection of analogues
▶
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.